Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu V Shvets

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Experimental Oncology|August 14, 2022
HUMAN MICROBIOTA AND BREAST CANCERYu V Shvets, O O Lykhova, V F Chekhun
Experimental Oncology|July 1, 2020
Human microbiota and effectiveness of cancer chemotherapyYu V Shvets, N Yu Lukianova, V F Chekhun
Experimental Oncology|March 26, 2015
Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicinI N Todor, N Yu Lukyanova, Yu V Shvets, et al.
Experimental Oncology|June 27, 2015
Pharmacological effect of aminoferrocene in mice with L1210 leukemiaV F Chekhun, A Mokhir, S Daum, et al.
Ukrainian Biochemical Journal|December 12, 2017
Remodulating effect of doxorubicin on the state of iron-containing proteins, and redox characteristics of tumor with allowance for its sensitivity to cytostatic agentsV F Chekhun, Yu V Lozovska, A P Burlaka, et al.
Ukrainian Biochemical Journal|August 11, 2015
METALLOPROTEINS DURING DEVELOPMENT OF WALKER-256 CARCINOSARCOMA RESISTANT PHENOTYPEV F Chekhun, Yu V Lozovska, A P Burlaka, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Experimental Oncology|August 14, 2022
HUMAN MICROBIOTA AND BREAST CANCERYu V Shvets, O O Lykhova, V F Chekhun
Experimental Oncology|July 1, 2020
Human microbiota and effectiveness of cancer chemotherapyYu V Shvets, N Yu Lukianova, V F Chekhun
Experimental Oncology|March 26, 2015
Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicinI N Todor, N Yu Lukyanova, Yu V Shvets, et al.
Experimental Oncology|June 27, 2015
Pharmacological effect of aminoferrocene in mice with L1210 leukemiaV F Chekhun, A Mokhir, S Daum, et al.
Ukrainian Biochemical Journal|December 12, 2017
Remodulating effect of doxorubicin on the state of iron-containing proteins, and redox characteristics of tumor with allowance for its sensitivity to cytostatic agentsV F Chekhun, Yu V Lozovska, A P Burlaka, et al.
Ukrainian Biochemical Journal|August 11, 2015
METALLOPROTEINS DURING DEVELOPMENT OF WALKER-256 CARCINOSARCOMA RESISTANT PHENOTYPEV F Chekhun, Yu V Lozovska, A P Burlaka, et al.
Pageof 1